A global drug development consultancy helping to translate ideas into medicinal products and treatments for the benefit of patients.
Operating out of our offices in the UK, EU and USA, the team at Boyds provides a wide range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices. We specialise in ATMPs, cell and gene therapies and orphan drugs, focusing on cutting-edge medicinal products and treatments.
Boyds works with pharma companies, biotechs, spin-outs and academic groups to support cutting-edge development
Supporting the strategic planning and tactical execution of development programmes.
Facilitating the efficient development of medicinal products, working with the MHRA, FDA and EMA.
Pharmaceutical Due Diligence
Thorough and comprehensive scientific due diligence, enabling our clients to make informed decisions.
Strategic advice and guidance to enable the delivery of Early Access Programmes and Real-World Data collection.